Reshaping the gene therapy landscape
with AI-powered AAV vectors

The Outlook

Gene therapies of the future will be designed using artificial intelligence (AI) to reach more patients and treat many more diseases.

Our Solution

Dyno Therapeutics is applying AI technology to discover novel gene therapy vectors with transformative delivery properties for a vast landscape of human diseases.

Our Science

Read about our founders' publication in Science, Nature Biotechnology, at ASGCT and more.


Dyno wins Xconomy's 2020
Startup of the Year award
Back to Top